|
The following links provide basic information about participating in clinical trials.
National Cancer Institute
National Cancer Institute (NCI) "About Clinical Trials"
http://www.nci.nih.gov/clinical_trials
National Institute of Health (NIH) "About Clinical Trials"
http://www.clinicaltrials.gov/ct/gui/info/resources
NIH's Clinical Trial Search
http://clinicaltrials.gov
Professional Organizations
Sarcoma Alliance for Research through Collaboration (SARC)
http://www.sarctrials.com/public/pag22.aspx
Advocacy for Rare Diseases
Kakkis Everylife Foundation
http://www.kakkis.org/
Other Organizations
Acurian
https://www.acurian.com/
American Cancer Society's "Clinical Trials"
http://www.cancer.org/docroot/ETO/ETO_6.asp
Canadian Cancer Society's "What Are Clinical Trials?"
http://www.cancer.ca/ccs/internet/standard/0,3182,3172_372029__langId-en,00.html
Coalition of National Cancer Cooperative Group's "Learn About Cancer Clinical Trials"
http://www.cancertrialshelp.org/Icare_content/icMainContent.aspx?intAppMode=1
CenterWatch Oncology Clinical Trials Listing
http://www.centerwatch.com/patient/studies/area12.html
MacMillan's "Clinical Trials"
http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Clinicaltrials.aspx
PhRMA's New Medicine's in Development - Sarcoma page
http://newmeds.phrma.org/results.php?drug=&indication=210&company=&status=
Understanding the Informed Consent Process
http://store.centerwatch.com/p-43-
understanding-the-informed-consent-process.aspx
Volunteering for a Clinical Trial Brochure
http://store.centerwatch.com/p-137-volunteering-for-a-clinical-trial.aspx
International Organizations
European Organisation for Research and Treatment of Cancer (EORTC) Clinical Trials (click on "Protocols Database")
http://www.eortc.be
The following links are to specific clinical trials and are recruiting patients.
Ridaforolimus - Ariad
Information that may be helpful for People Diagnosed with Metastatic Sarcoma regarding the SUCCEED Clinical Trial Currently Enrolling Patients.
ARIAD Pharmaceuticals has launched an international Phase 3 clinical trial of Rideforolimus, a novel mTOR inhibitor, in patients with metastatic soft-tissue and bone sarcomas. Patients who are currently receiving chemotherapy for the treatment of their sarcoma may wish to discuss the SUCCEED trial with their doctors to see if it may be right for them. For more information about the trial or to find a trial site nearby, you can visit www.succeedtrial.com <http://www.succeedtrial.com/> or call toll-free 1-877-621-2302 or internationally 1-617-621-2302 or email at ClinicalTrials@ARIAD.com <mailto:ClinicalTrials@ARIAD.com>
Pazopanib - GlaxoSmithKline
GlaxoSmithKline is actively recruiting participants for an international Phase III, double-blind trial of pazopanib in patients with soft tissue sarcoma. Pazopanib is an oral angiogenesis inhibitor targeting VEGFR, PDGFR and cKit. Eligible subjects may have received a maximum of 4 prior lines of systemic therapies (including up to 2 combination regimens) for advanced disease, including an anthracycline-based regimen; (neo)adjuvant/maintenance treatments are not counted against this criterion. Other primary inclusion criteria include confirmed disease progression, metastatic and not only locally advanced disease and measurable disease according to RECIST criteria. No liposarcomas (all subtypes), Ewing tumors or GIST tumors are eligible. See Clintrials.gov Identifier NCT00753688 for complete eligibility criteria and participating centres
Other Trials:
International Clinical Trial on Ewing Sarcoma: Click Here
http://www.clinicaltrials.gov/ct/show/NCT00233948?order=1
Investigator: Warren Chow, MD email: WChow@coh.org |
